Waksal’s Kadmon said to plan IPO, without Waksal By: CNBC.com News February 02, 2016 at 15:33 PM EST Kadmon, the biotechnology company founded by ImClone's Sam Waksal, is preparing to file confidentially for an initial public offering, sources say. Read More >> Related Stocks: Eli Lilly